Pancreatic Cancer PDX Models

Patient derived xenograft (PDX) models provide a predictive preclinical model for the evaluation of an agent’s efficacy prior to entering the clinic. The CrownBio collection of pancreatic PDX contains over 100 models, including models of both North American and Asian descent. More

Patient-derived xenografts (PDX) offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials.
CrownBio’s HuPrime® PDX collection well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL ID CANCER TYPE SUBTYPE models per page
PA0372 Pancreatic Cancer ADC VIEW MODEL Details
PA0527 Pancreatic Cancer ADC VIEW MODEL Details
PA0573 Pancreatic Cancer NA VIEW MODEL Details
PA0692 Pancreatic Cancer ADC VIEW MODEL Details
PA0787 Pancreatic Cancer ADC VIEW MODEL Details
PA0968 Pancreatic Cancer ADC VIEW MODEL Details
PA1168 Pancreatic Cancer Ductal adenocarcinoma VIEW MODEL Details
PA1170 Pancreatic Cancer Ductal adenocarcinoma VIEW MODEL Details
PA1178 Pancreatic Cancer Ductal adenocarcinoma VIEW MODEL Details
PA1189 Pancreatic Cancer Ductal adenocarcinoma VIEW MODEL Details